D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
PUT
Broadridge
BR
$18.3B
| $1.98M | ﹤0.01% |
+20,900
| New | +$2.38M |
|
2102
Protagonist Therapeutics
PTGX
$8.78B
| $1.98M | ﹤0.01% |
280,534
-149,983
| -35% | -$1.12M |
|
2103
CALL
Wolfspeed
WOLF
$1.13B
| $1.98M | ﹤0.01% |
55,800
-32,000
| -36% | -$1.44M |
|
2104
CALL
PG&E
PCG
$39.3B
| $1.98M | ﹤0.01% |
220,000
| – | – |
|
|
EFOR
2105
Everforth Inc
EFOR
$942M
| $1.97M | ﹤0.01% |
55,870
+35,699
| +177% | +$2.02M |
|
2106
Innovative Industrial Properties
IIPR
$1.76B
| $1.97M | ﹤0.01% |
25,963
+16,644
| +179% | +$1.41M |
|
2107
Universal Electronics
UEIC
$58.5M
| $1.96M | ﹤0.01% |
51,125
+18,762
| +58% | +$850K |
|
2108
Canadian Pacific Kansas City
CP
$81.4B
| $1.96M | ﹤0.01% |
44,650
-8,595
| -16% | -$423K |
|
|
LKFT
2109
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $1.96M | ﹤0.01% |
10,000
| – | – |
|
|
BZUN
2110
PUT
Baozun
BZUN
$167M
| $1.96M | ﹤0.01% |
70,000
+40,000
| +133% | +$1.26M |
|
2111
iShares MSCI Brazil ETF
EWZ
$9.12B
| $1.96M | ﹤0.01% |
+83,021
| New | +$3.21M |
|
2112
PUT
Intuit
INTU
$85.4B
| $1.96M | ﹤0.01% |
8,500
-12,400
| -59% | -$3.36M |
|
2113
CryoPort
CYRX
$763M
| $1.95M | ﹤0.01% |
114,481
-18,183
| -14% | -$318K |
|
2114
PUT
Seagate
STX
$168B
| $1.95M | ﹤0.01% |
40,000
-58,800
| -60% | -$3.14M |
|
|
FRTA
2115
DELISTED
Forterra, Inc
FRTA
| $1.95M | ﹤0.01% |
325,620
-154,201
| -32% | -$1.76M |
|
|
EV
2116
DELISTED
Eaton Vance Corp.
EV
| $1.95M | ﹤0.01% |
60,308
-32,929
| -35% | -$1.4M |
|
2117
KBR
KBR
$4.74B
| $1.94M | ﹤0.01% |
+93,943
| New | +$2.43M |
|
2118
PUT
American Express
AXP
$227B
| $1.93M | ﹤0.01% |
22,500
+20,400
| +971% | +$2.37M |
|
|
QEP
2119
DELISTED
QEP RESOURCES, INC.
QEP
| $1.92M | ﹤0.01% |
5,738,225
+198,929
| +4% | +$479K |
|
2120
West Pharmaceutical
WST
$23.8B
| $1.92M | ﹤0.01% |
12,607
-13,848
| -52% | -$2.13M |
|
2121
CALL
Pan American Silver
PAAS
$18.2B
| $1.92M | ﹤0.01% |
133,800
| – | – |
|
2122
Conagra Brands
CAG
$7.39B
| $1.92M | ﹤0.01% |
65,296
-430,082
| -87% | -$13M |
|
|
OXFD
2123
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.92M | ﹤0.01% |
206,913
+15,758
| +8% | +$220K |
|
2124
Western Alliance Bancorporation
WAL
$9.11B
| $1.91M | ﹤0.01% |
+62,523
| New | +$2.99M |
|
|
2125
Intuit
INTU
$85.4B
| $1.91M | ﹤0.01% |
8,312
-44,297
| -84% | -$12M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.